9 Meters Biopharma, Inc. (NMTR) Misses Q1 EPS by 98c

9 Meters Biopharma, Inc. (NASDAQ: NMTR) reported Q1 EPS of ($1.02), $0.98 worse than the analyst estimate of ($0.04).

For earnings history and earnings-related data on 9 Meters Biopharma, Inc. (NMTR) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Pinduoduo (PDD) Tops Q2 EPS by 98c
• Macquarie Downgrades Tongcheng Travel Holdings Ltd (780:HK) to Neutral